Allium sativum potentiates suicide gene therapy for murine transitional cell carcinoma

Nutrition and Cancer
D G MoonS K Koh

Abstract

This study evaluated the synergistic effect of Allium sativum (AS) with suicide gene therapy for transitional cell carcinoma (TCC) of the bladder. Subcutaneous TCCs were established in syngeneic C3H/He mice with 1 x 10(5) MBT-2 cells. AS liquid extract was injected at the site of tumor transplantation on Day 1 for three weeks (Experiment I) and into the established tumors weekly for five weeks (Experiment II) in combination with or without gene therapy using a replication-defective adenoviral vector containing a herpes simplex virus thymidine kinase (HSV-TK) gene under the transcriptional control of Rous sarcoma virus (RSV) promoter (Ad-RSV-TK, 5 x 10(8) plaque-forming units) plus ganciclovir (20 mg/kg/day i.p.). AS demonstrated a statistically significant reduction in incidence of TCC (cumulative dose 25 mg of AS). Combination AS-suicide gene therapy significantly inhibited the tumor growth compared with the controls, which was evidenced by apoptosis on histomorphological and immunohistochemical studies. These results suggest that AS had a definite antitumor effect in inhibiting tumorigenesis and growth of TCC in a murine model. AS treatment combined with suicide gene therapy had significant additive antitumor effects on TCC a...Continue Reading

References

Feb 1, 1976·The Journal of Urology·M A Mufson, R B Belshe
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·G B ElionH J Schaeffer
Feb 21, 1990·Journal of the National Cancer Institute·F L Moolten, J M Wells
Nov 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W G HarkerF M Torti
Jan 1, 1995·British Medical Bulletin·K W CulverT Seregina
Nov 1, 1994·Journal of Neuroscience Research·M J Perez-CruetH D Shine
May 14, 1993·Science·R C Mulligan

❮ Previous
Next ❯

Citations

Mar 29, 2014·Expert Opinion on Drug Discovery·Paula A OliveiraCarmen Vasconcelos-Nóbrega
Apr 4, 2003·Nutrition and Cancer·Annu Arora, Yogeshwer Shukla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis